Anna Santarsieri
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.
Journal: Haematologica
Published: January 21, 2026
Post-transplant lymphoproliferative disorder following multivisceral transplantation: Incidence, risk factors, and outcomes in an adult UK cohort.
Journal: Intestinal Failure (New York, N.Y.)
Published: October 28, 2025
Author Correction: The long-term effects of chemotherapy on normal blood cells.
Journal: Nature genetics
Published: July 31, 2025
Extranodal Lymphoplasmacytic Lymphoma Responding Rapidly to Zanubrutinib: A Case Series.
Journal: Clinical case reports
Published: March 19, 2025
The long-term effects of chemotherapy on normal blood cells.
Journal: Nature genetics
Published: September 11, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study.
Journal: The Lancet. Oncology
Published: July 18, 2024
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
Journal: Blood advances
Published: July 14, 2023
Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era.
Journal: Cancers
Published: October 04, 2022
Relapsed mantle cell lymphoma presenting with lactic acidosis and hypoglycemia: A case report.
Journal: Clinical case reports
Published: August 05, 2022
Incidence and outcomes of post-transplant lymphoproliferative disease after 5365 solid-organ transplants over a 20-year period at two UK transplant centres.
Journal: British journal of haematology
Published: November 04, 2021
Last Updated: 09/26/2026